Skip to content
10-Q

Quarterly Report

NAVIDEA BIOPHARMACEUTICALS, INC.

0001437749-23-023319

← back to feed
Filed
Aug 11, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 9, 2023 99.83M sh
Capex Q2 2023 · Jun 30, 2023 $15.07K
Capex Q2 2023 · Jun 30, 2022 $48.66K
Capex Q2 2023 · Jun 30, 2022 $48.66K
Operating Cash Flow Q2 2023 · Jun 30, 2023 $2.97M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$4.7M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $6.14M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $2M
Stockholders Equity Q2 2023 · Jun 30, 2023 −$1.08M
Stockholders Equity Q2 2023 · Dec 31, 2022 −$8.44M
Current Liabilities Q2 2023 · Jun 30, 2023 $8.31M
Current Liabilities Q2 2023 · Dec 31, 2022 $9.94M
Total Liabilities Q2 2023 · Jun 30, 2023 $9.01M
Total Liabilities Q2 2023 · Dec 31, 2022 $12.51M
Current Assets Q2 2023 · Jun 30, 2023 $7M
Current Assets Q2 2023 · Dec 31, 2022 $3.2M
Total Assets Q2 2023 · Jun 30, 2023 $8.22M
Total Assets Q2 2023 · Dec 31, 2022 $4.37M
Eps Basic Q2 2023 · Jun 30, 2023 $0.12
Eps Basic Q2 2023 · Jun 30, 2023 $0.11
Eps Basic Q2 2023 · Jun 30, 2022 −$0.10
Eps Basic Q2 2023 · Jun 30, 2022 −$0.20
Sga Expense Q2 2023 · Jun 30, 2023 $1.32M
Sga Expense Q2 2023 · Jun 30, 2023 $2.48M
Sga Expense Q2 2023 · Jun 30, 2022 $1.26M
Sga Expense Q2 2023 · Jun 30, 2022 $3.07M
Rd Expense Q2 2023 · Jun 30, 2023 $1.11M
Rd Expense Q2 2023 · Jun 30, 2023 $2.37M
Rd Expense Q2 2023 · Jun 30, 2022 $1.72M
Rd Expense Q2 2023 · Jun 30, 2022 $2.89M
Operating Income Q2 2023 · Jun 30, 2023 −$2.43M
Operating Income Q2 2023 · Jun 30, 2023 −$4.85M
Operating Income Q2 2023 · Jun 30, 2022 −$2.92M
Operating Income Q2 2023 · Jun 30, 2022 −$5.9M
Gross Profit Q2 2023 · Jun 30, 2023 $0
Gross Profit Q2 2023 · Jun 30, 2023 $0
Gross Profit Q2 2023 · Jun 30, 2022 $57.05K
Gross Profit Q2 2023 · Jun 30, 2022 $57.05K
Revenue Q2 2023 · Jun 30, 2023 $0
Revenue Q2 2023 · Jun 30, 2023 $0
Revenue Q2 2023 · Jun 30, 2022 $57.53K
Revenue Q2 2023 · Jun 30, 2022 $57.53K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $473
Cost Of Revenue Q2 2023 · Jun 30, 2022 $473